cyst recurrence, which has been found to be 1.8% in the lumbar region when fusion is not performed. 7 However, the role of instrumentation to improve symptomatology and prevent cyst recurrence has not been well established in the cervical spine.
In this article, we first present a series of 17 cases of surgically managed CSCs from our institutional experience. We also report the results of a meta-analysis of case reports and case series involving CSCs, which we conducted in order to compare outcomes in patients with atlantoaxial versus subaxial cysts and in patients treated with and without spinal fusions.
Methods

Current Series
We performed a retrospective electronic medical record review of cases of surgically treated symptomatic cervical spine and cervicothoracic junction (C-1 to T-1) synovial cysts either proven by pathology or (when not excised) identified intraoperatively at our institution from 1991 to 2013. Data were gathered from electronic records of clinical interviews and examinations, surgical narratives, radiology reports, pathology reports, and follow-up visits. Variables collected included patient age, sex, relevant medical history, imaging findings, presenting symptoms, surgical intervention performed, and follow-up times. Our main outcome variables were symptom resolution at last followup, last reported Nurick scores, and cyst recurrences.
Meta-Analysis
The PRISMA guidelines were followed in preparation of this article. 44 A comprehensive online search was conducted via PubMed on August 1, 2013, using the key words "cervical spine synovial cyst," "cervical spine ganglion cyst," "cervical spine degenerative cyst," and "cervical spine juxtafacet cyst." The results are presented in Fig. 1 . Duplicates and articles written in a language other than English were excluded.
Abstracts were reviewed and included if they reported patients with a proven diagnosis of cervical spine or cervicothoracic junction (C-1 to T-1) synovial cyst by either pathology or intraoperative findings. This selection process yielded a total of 84 articles. The articles were reviewed by hand and excluded from our meta-analysis if: 1) no individual patient information (age, sex, presenting symptom, treatment, and outcome) was given, or 2) no follow-up time was mentioned. We also cross-referenced articles to reduce publication bias. This reduced our selection to 53 articles that were included quantitatively in our meta-analysis. The same variables as recorded in our series were collected in our review whenever possible. The primary end points were symptoms at last follow-up, last follow-up Nurick scores, and cyst recurrences.
Statistical Analysis
Statistical analysis was performed using STATA12 (StataCorpLP). Demographic variables are reported as mean ± standard deviation when appropriate. The Student t-test and the c 2 test were used to compare continuous variables and nominal variables, respectively, between subgroups. Statistical significance was set at p < 0.05.
Results
Current Series
Seventeen patients were identified; their characteristics are summarized in Table 1 . The patients' mean age at presentation was 63.7 ± 13.7 years, and 52.9% of patients were male. The most common relevant preoperative finding was rheumatoid arthritis (present in 3 patients [17.64%]), and the most common associated radiographic finding was degenerative disc disease (present in 16 [94.1%]). A total of 3 patients presented with atlantoaxial cysts, whereas 14 patients presented with subaxial cysts. The most common presenting symptoms were radiculopathy (88.2% of cases) and motor deficits (70.5%). The mean duration of symptoms before surgery was 5.1 months (range 1-12 months). The average preoperative Nurick score was 1.35. Sixteen patients (94.2%) were treated with decompression, cyst excision, and fusion; 1 patient underwent decompression only. After a mean follow-up duration of 25.4 months, the majority of patients had improvement in their symptoms, there were no cyst recurrences, and the mean value for the last reported Nurick score was 0.58.
Meta-Analysis
A total of 53 previous publications that reported on 84 cases were included in our meta-analysis and are summarized in Table 2 . [1] [2] [3] [4] 6, [8] [9] [10] [11] [12] 15, 17, [19] [20] [21] [22] [25] [26] [27] [28] [29] [30] [31] 33, 34, 36, 38, 39, 42, 43, [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [56] [57] [58] [60] [61] [62] [63] [64] [66] [67] [68] [69] We also included our own 17 cases from the present study in the analysis, bringing the total number of articles to 54 and the total number of patients to 101. There were 10 case series (including the present study) and 44 case reports. The patients' mean ages at presentation ranged from 55.3 to 75.4 years, and the mean followup times ranged from 1.5 to 40.2 months.
A total of 101 patients underwent surgical management of CSCs (mean age 64 ± 13.9 years) ( Table 3) . Of these 101 patients, 56 (55.4%) were male, and the most common relevant history findings were cervical spine trauma (10.9% of cases) and congenital fusion (7.9%). Radiographically, 26.7% of patients had degenerative disc disease, and 18.8% had spondylolisthesis. The most common presenting symptoms were motor deficits (84.2% of patients) and sensory deficits (61.4%). The mean duration of symptoms was 4.9 months and the mean preoperative Nurick score was 2.05 ± 1.9. The most common cyst location was C7-T1 (42 cases) (Fig. 2) . A total of 52 patients (51.4%) underwent decompression only and 49 (48.6%) were treated with instrumented fusion with or without decompression. Most patients experienced improvement in their symptoms, and no cysts recurred. The mean Nurick score at last follow-up was 0.81. Patients were followed for a mean duration of 16.5 months (range 1-66 months).
Atlantoaxial Versus Subaxial Cysts
Patients were first divided according to cyst location into atlantoaxial (n = 41) and subaxial (n = 60) groups (Ta-J Neurosurg: Spine / Volume 21 / December 2014 ble 4). The subaxial group included a significantly higher number of male patients (p = 0.019), patients who had previously undergone cervical fusion (p = 0.023), and patients with associated degenerative disc disease (p = 0.004). On the other hand, the atlantoaxial group had a significantly higher number of patients with congenital cervical fusions (p = 0.039). In terms of presenting symptoms, a significantly higher number of patients in the subaxial cyst group presented with radiculopathy (p < 0.001). Surgical outcomes were similar in the 2 groups, with no significant differences in Nurick scores, symptom resolution, or cyst recurrences. Patients in the atlantoaxial cohort were followed for a significantly longer time (p = 0.04).
Decompression Only Versus Decompression and Fusion
Lastly, patients were categorized into those who underwent decompression alone (n = 52) and those who underwent decompression and fusion (n = 49) ( Table 5) . The 2 cohorts did not significantly differ in preoperative characteristics, including age, sex, relevant history, and radiographic findings. Presenting symptoms were also similar, with the exception of a higher incidence of radiculopathy in the fusion cohort (p = 0.023). Preoperative Nurick scores were significantly lower in the fusion group (p = 0.001), with an average score of 1.32 compared with 2.75 in the decompression-only group.
Improvement in symptoms at last follow-up differed significantly with respect to only one measure: a higher percentage of patients in the decompression-only cohort had improvement in bowel/bladder function (p = 0.40) when compared with patients who additionally underwent a fusion. Comparison of preoperative and postoperative Nurick scores showed significant improvement in both groups. A difference of means analysis between final and preoperative Nurick scores revealed that scores for patients who received decompression alone improved on average 1.66 points (95% CI 1.03, 2.29) compared with 0.8 points (95% CI 0.23, 1.39) in the fusion group (p = 0.004).
Cyst recurrence was not observed in either cohort. The mean follow-up time was 13.6 months in the decompression-only group and 19.26 months in the fusion group, but this difference did not reach statistical significance (p = 0.05).
Discussion
Synovial and ganglion cysts may arise in joints of the upper and lower extremities and also in the spine. The differentiation of these lesions relies on histopathological examination, 4 with synovial cysts ("true cysts") presenting a synovial lining, direct attachment to the joint, and clear or xanthochromic fluid. 30 Ganglion cysts, in contrast, have been called "pseudo-cysts" and are not directly connected to the joint; they have a fibrous connective tissue capsule instead of synovial tissue, and a gelatinous fluid. 56 Nonetheless, the presenting symptoms, management, and prognosis of these 2 types of lesions are the virtually the same. 23 In the spine, these cysts may occur at the juxtafacet joints, median atlantoaxial joints, atlantoocciptal joints, and/or ligamentous structures. 38 The etiology and pathogenesis of cervical synovial cysts (CSCs) is poorly understood, and it is hypothesized that these cysts develop in the degenerated and segmentally unstable spine. 15, 41 Spinal degeneration is thought to cause synovial membrane protrusion through small joint capsule defects, forming a para-articular cavity. 5 Furthermore, current evidence suggests that the mechanical stress on the spine induces an inflammatory cascade (upregulation and release of interleukin-1, interleukin-6, platelet-derived growth factor, and vascular endothelial growth factor, among other cytokines) that ultimately leads to neovascularization and hyperplasia of the synovium and exudation of fluid. 16, 59 Other theories that attempt to explain cyst formation include the myxoid degeneration, 14, 20 trauma, 9, 28 and chronic joint capsule weakness theories. 52, 58 Our meta-analysis revealed associated degenerative disc disease and spondylolisthesis in 26.7% and 18.8% of patients, respectively; this supports, in particular, the mechanical stress theory, 15 ,41 but does not account for all cases. Other associated findings in our meta-analysis were a history of spine trauma in 10.9% of patients, congenital fusion in 7.9%, and rheumatoid arthritis in 4.9%. These findings suggest that CSC pathogenesis is most likely multifactorial in nature. The currently accepted treatment for CSCs is surgical intervention (Fig. 3) . 4 However, there is no consensus on the optimal technique. Although the most common procedure is decompression and excision, instrumented fusion is often added for cases with underlying instability or potential iatrogenic instability or to eliminate the risk of recurrence. In line with this query, we compared patients who underwent decompression only versus fusion and assessed their outcomes.
We found 52 patients who underwent decompression 1-4,6,9,11,12,15,17,19,20,22,25,26,28- difference between groups in terms of age, sex, or medical history. Symptom resolution was found to be the same in both groups, except that a higher number of patients treated only with decompression experienced resolution of their bowel/bladder dysfunction (Table 4) . Moreover, we found no reported cyst recurrences in surgically treated patients irrespective of fusion status. Because these cysts are thought to arise from abnormal movement and/or segmental instability, stabilization is often employed to eliminate the source of the cyst (diseased facet joint) and prevent recurrence. In our meta-analysis, we found 4 publications citing treatment with only instrumented fusion (without cyst excision) for atlantoaxial cysts, and interestingly, all patients experienced symptom resolution and cyst regression. 10, 27, 46, 66 The authors of these 4 papers attributed cyst development to abnormal segmental motion and emphasized the ben- efits of fusion. In the systematic review of lumbar synovial cysts by Bydon et al., 7 risk of recurrence was higher in patients who did not undergo instrumented fusion (1.8%) compared with patients who did undergo fusion. However, these results cannot be currently extrapolated to the cervical spine, where we found no difference in cyst recurrence between the fusion and decompressiononly groups. However, it should be stated that this finding may be a function of the length of follow-up time. 10, 27, 46, 66 Indeed, synovial cyst recurrences have been reported to occur up to 60 months after initial decompression. 32 Patients who present with a symptomatic CSC may benefit from fusion if they also have facet disease, multilevel degenerative disc disease, sagittal deformity, spondylolisthesis, or iatrogenic instability due to the decompression. 35, 40 In determining whether a fusion is warranted, preoperative flexion-extension radiographs may be helpful in revealing occult mechanical instability (Fig.  4) . 24 Additionally, extensive drilling of the facet joints intraoperatively may result in iatrogenic instability. Several studies have shown that resection of more than 50% of the facet joint is associated with increased instability postoperatively. 18, 65 Voo et al. found that facet resections exceeding 50% in the cervical spine result in significant increases in annulus stresses and segmental mobility. 65 In our case series, 94.1% of patients presented with additional degenerative disc disease and 58.8% with spondylolisthesis, and all patients except one underwent a fusion procedure accordingly. These findings, combined with the fact that synovial cysts are typically a disease of the elderly and oftentimes seen at the cervicothoracic junction, point to underlying spinal instability as a culprit. 15, 41 While surgical outcomes in cases of antlantoaxial and subaxial cysts were similar in the current meta-analysis, these lesions differ in their typical presenting symptoms and treatments. 37 Patients with atlantoaxial cysts more often present with myelopathy, whereas those with subaxial cysts may present with myelopathy and/or radiculopathy. Moreover, atlantoaxial cysts can be treated via either a posterior or a transoral approach, while treatment of subaxial cysts is exclusively done via a posterior approach. The similar outcomes reported herein could be attributed to a relatively small sample size, which might result in the study being underpowered.
When taking into account only symptom resolution and cyst recurrence after decompression for CSCs, we found no difference between fused and nonfused patients. Patients who did not undergo a fusion were found to have a greater improvement in Nurick score than patients treated with fusion; however, the patients in the decompression-only group had higher preoperative Nurick scores and thus more room for improvement. The difference in severity of presenting symptoms was likely due to underlying variations in the pathogenesis of CSCs in the presence versus absence of concurrent spinal disease requiring fusion.
Limitations
In this manuscript, we present the first meta-analysis of cases of CSCs specifically comparing surgical outcomes in patients treated with decompression alone versus outcomes in those treated with decompression and fusion. However, retrospective studies have inherent limitations, and additional objective measures such as the Japanese Orthopaedic Association or SF-36 health survey scores could not be assessed. Additionally, average follow-up time was also a significant limitation; while the mean follow-up time in our series was 25.4 months, overall mean follow-up time in the meta-analysis was 16.5 months. Prospective, randomized studies may help to broaden our understanding of the optimal treatment of CSCs. 
Conclusions
The occurrence of synovial cysts in the cervical spine is rare but well documented. Our institutional case series included 17 patients, and all but one underwent decompression and fusion. The literature review revealed that symptom resolution and cyst resolution were similar whether or not fusion was performed. However, the lack of cyst recurrence in the cervical spine may be a function of follow-up time (mean 16.5 months). Additionally, the most common location was the cervicothoracic junction, and 18.8% of patients presented with underlying spondylolisthesis, both factors pointing to instability as a likely etiological factor. Biomechanical and prospective studies are needed to further understand and corroborate our findings.
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